<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H103FF96C8BE14A9D95FB12A2BED648CE" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 1794 IH: United States-Abraham Accords Cooperation and Security Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-03-03</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1794</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250303">March 3, 2025</action-date><action-desc><sponsor name-id="H001086">Mrs. Harshbarger</sponsor> (for herself, <cosponsor name-id="V000130">Mr. Vargas</cosponsor>, <cosponsor name-id="W000814">Mr. Weber of Texas</cosponsor>, <cosponsor name-id="P000608">Mr. Peters</cosponsor>, <cosponsor name-id="H001052">Mr. Harris of Maryland</cosponsor>, and <cosponsor name-id="L000593">Mr. Levin</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to establish an Abraham Accords Office within Food and Drug Administration, and for other purposes.</official-title></form><legis-body id="HF7A356865C11424DB8AED26D3F7D8F6E" style="OLC"> 
<section id="H0C97FB37BC264F9BBB27D9ED151EAC88" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>United States-Abraham Accords Cooperation and Security Act of 2025</short-title></quote>.</text></section> <section id="HD950EAD579274FA8B377C451440526AE"><enum>2.</enum><header>Establishment of Abraham Accords Office within Food and Drug Administration</header> <subsection id="H3EAB923D082B44DC8EA6AC0C7C2D7289"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Chapter X of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/391">21 U.S.C. 391 et seq.</external-xref>) is amended by adding at the end the following:</text> 
<quoted-block style="OLC" id="HBD1233F0202C41CC8C4D03AFE39C0E28" display-inline="no-display-inline"> 
<section id="HA14CD185128649C0BF6C40FD44F084BE"><enum>1015.</enum><header>Abraham Accords Office</header> 
<subsection id="H778E76558BF24138973891B6DE2923E3"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary, acting through the Commissioner of Food and Drugs, shall establish within the Food and Drug Administration an office, to be known as the Abraham Accords Office, to be headed by a director.</text></subsection> <subsection id="HC975A0AA6EF74C7F8152B3D5084581DB"><enum>(b)</enum><header>Office</header><text display-inline="yes-display-inline">Not later than 2 years after the date of enactment of this section, the Secretary shall—</text> 
<paragraph id="HE4B55566E5844F2B80E7E4B57B179985"><enum>(1)</enum><text display-inline="yes-display-inline">in consultation with the governments of Abraham Accords countries, as well as appropriate United States Government diplomatic and security personnel—</text> <subparagraph id="H88D57B4FAB674AC8A862F88A4F9CDAE8"><enum>(A)</enum><text>select the location of the Abraham Accords Office in an Abraham Accords country; and</text></subparagraph> 
<subparagraph id="HA6E916D3767944A5B4F57B0580119158"><enum>(B)</enum><text>establish such office; and</text></subparagraph></paragraph> <paragraph id="HD0312BF0FF5D479C97DDC34D229D9872"><enum>(2)</enum><text>assign to such office such personnel of the Food and Drug Administration as the Secretary determines necessary to carry out the functions of such office.</text></paragraph></subsection> 
<subsection id="H198C1912A09145D59837E3615DD92301"><enum>(c)</enum><header>Duties</header><text display-inline="yes-display-inline">The Secretary, acting through the Director of the Abraham Accords Office, shall—</text> <paragraph id="H6E99A40B62AD4604A365B528568AB14E"><enum>(1)</enum><text display-inline="yes-display-inline">after the Abraham Accords Office is established—</text> 
<subparagraph id="H6CA6EBFCCD284184BCF312CADFEE5266"><enum>(A)</enum><text display-inline="yes-display-inline">as part of the Food and Drug Administration’s work to strengthen the international oversight of regulated commodities, provide technical assistance to regulatory partners in Abraham Accords countries on strengthening regulatory oversight and converging regulatory requirements for the oversight of regulated products, including good manufacturing practices and other issues relevant to manufacturing medical products that are regulated by the Food and Drug Administration; and</text></subparagraph> <subparagraph id="HE3422241D2D24E46A3BB4CEE09642991"><enum>(B)</enum><text display-inline="yes-display-inline">facilitate interactions between the Food and Drug Administration and interested parties in Abraham Accords countries, including by sharing relevant information regarding United States regulatory pathways with such parties, and facilitate feedback on the research, development, and manufacturing of products regulated in accordance with this Act; and </text></subparagraph></paragraph> 
<paragraph id="H2D1EF2ABC1634D5FA920D8AA3893BCCB"><enum>(2)</enum><text display-inline="yes-display-inline">carry out other functions and activities as the Secretary determines to be necessary to carry out this section.</text></paragraph></subsection> <subsection id="H6B4D06D89C034842B734A5829A3D85E0"><enum>(d)</enum><header>Abraham Accords country defined</header><text>In this section, the term <term>Abraham Accords country</term> means a country identified by the Department of State as having signed the Abraham Accords Declaration.</text></subsection> 
<subsection id="HDABCB760EFB24BEB981A599A4D399DC3"><enum>(e)</enum><header>National security</header><text>Nothing in this section shall be construed to require any action inconsistent with a national security recommendation provided by the Federal Government.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subsection> <subsection id="HAE5DE65160B0496495791BA735C149D1"><enum>(b)</enum><header>Report to Congress</header> <paragraph id="HAA5E2064B6E3483DA827DD7989D4BB7D"><enum>(1)</enum><header>In general</header><text>Not later than 3 years after the date of enactment of this Act, the Secretary of Health and Human Services shall submit to the Congress a report on the Abraham Accords Office, including—</text> 
<subparagraph id="HB73C4ED56C254BEC8A9A003E8FDFBDCC"><enum>(A)</enum><text display-inline="yes-display-inline">an evaluation of how the Office has advanced progress toward conformance with Food and Drug Administration regulatory requirements by manufacturers in the Abraham Accords countries;</text></subparagraph> <subparagraph id="H51EFCF942A20405BB24B0839CD501AC3"><enum>(B)</enum><text display-inline="yes-display-inline">a numerical count of parties that the Office has helped facilitate interactions or feedback pursuant to section 1015(c)(1)(B) of the Federal Food, Drug, and Cosmetic Act (as added by subsection (a));</text></subparagraph> 
<subparagraph id="H7F5BC6CE412E412BBE9D1D1AC0D4563D"><enum>(C)</enum><text display-inline="yes-display-inline">a summary of technical assistance provided to regulatory partners in Abraham Accords countries pursuant to subparagraph (A) of such section 1015(c)(1); and </text></subparagraph> <subparagraph id="H51C580A504904CB9AA4573C9CA161157"><enum>(D)</enum><text display-inline="yes-display-inline">recommendations for increasing and improving coordination between the Food and Drug Administration and entities in Abraham Accords countries.</text></subparagraph></paragraph> 
<paragraph id="H8D5F04E2D15A4A2D8A46EC9631A6FF97"><enum>(2)</enum><header>Abraham Accords country defined</header><text>In this subsection, the term <term>Abraham Accords country</term> has the meaning given such term in section 1015(d) of the Federal Food, Drug, and Cosmetic Act (as added by subsection (a)).</text></paragraph></subsection></section> </legis-body></bill>

